Genprex stockholders approve reverse stock split authorization and 1.85M share increase to equity plan

Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm. The proposal to ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was approved by the stockholders based upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 4,284,497 254,937 55,594 0

Proposal 1. Election of Directors. The Class III director nominees, Jose Antonio Moreno Toscano and Ryan M. Confer, were elected to serve until the 2029 annual meeting of stockholders and until their respective successors have been duly elected and qualified, or until each such director’s earlier resignation, removal or death. The result of the votes to elect the Class III directors were as follows: Name Votes For Votes Withheld Broker Non-Votes Jose Antonio Moreno Toscano 868,543 176,863 3,549,622 Ryan M. Confer 877,370 168,036 3,549,622

Proposal 4. Approval of the Company’ s Amended and Restated 2018 Equity Incentive Plan. The proposal to approve the Amended Equity Plan was approved by the stockholders based upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 675,090 337,920 32,396 3,549,622

Proposal 3. Advisory Vote on Compensation of Named Executive Officers ( “ NEOs ” ). The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company’s NEOs as described in the Company’s Proxy Statement: Votes For Votes Against Abstention Broker Non-Votes 681,841 328,425 35,140 3,549,622

Proposal 5. Adoption and Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation. The amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s issued shares of common stock, at a specific ratio, ranging from one-for-five (1:5) to one-for-fifty (1:50), at any time prior to December 31, 2027, subject to the Company’s Board of Directors’ determination, in its sole discretion, whether or not to implement the reverse stock split and, if so, at what specific ratio within the foregoing range, without further approval or authorization of the Company’s stockholders, was approved by the stockholders upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 2,941,032 1,592,728 61,268 0